Richtsmeier Brent 4

What Happened Brent Richtsmeier, Chief Technology Officer of TransAct Technologies, reported exercising/converting derivative awards into common stock. The filing shows conversions on Feb 28, Mar 1 and Mar 2, 2026 totaling 8,303 shares (1,300 + 4,778 + 1,250 + 975). The reported transaction amounts list price as N/A; the filing records both the acquisition of shares and the corresponding disposition of the derivative instruments (code M = exercise or conversion).

Key Details

• Transaction dates and amounts:
  • 2026-02-28: 1,300 shares converted
  • 2026-03-01: 4,778 shares converted
  • 2026-03-01: 1,250 shares converted
  • 2026-03-02: 975 shares converted
  • Total converted: 8,303 shares
• Price: listed as N/A in the filing (no cash price reported).
• Shares owned after the transactions: not specified in the provided filing excerpt.
• Footnotes: conversions relate to previously granted awards that converted to common stock on a one-for-one basis:
  • F1: RSUs granted 2/29/2024 (25% annual vesting)
  • F2: PSUs granted 3/1/2023 (vesting in three installments: 3/1/24, 3/1/25, 3/1/26)
  • F3: RSUs granted 3/1/2023 (25% annual vesting)
  • F4: RSUs granted 3/2/2022 (25% annual vesting)
• Filing date: Form 4 filed 2026-03-02 (covering transactions through 2026-03-02). The filing excerpt does not indicate lateness.

Context

• Code M denotes an exercise or conversion of a derivative instrument. Here the filing shows the derivative instruments were converted into common shares (the derivative was disposed and common shares were acquired), not an open-market purchase or sale of existing shares.
• Because price info is N/A and the shares derive from prior equity awards (RSUs/PSUs), this is a routine conversion/vesting event rather than an outright purchase or an open-market sale. These kinds of filings document grant vesting/exercise activity and do not by themselves indicate a buy/sell opinion.